Clinical Trials
92 trialsSCLC Tarlatamab Blood Collection
Duke University
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
NYULCBC
NYU Langone Health
Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
Shanghai Chest Hospital
LUNGEVITY
Groupe Francais De Pneumo-Cancerologie
COMETH
University of Kansas Medical Center
Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
Medical University of Bialystok
IKF-ReWoLuTe
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
PHILUCA
Zealand University Hospital
Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)
Peking University Cancer Hospital & Institute
CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
Shandong Cancer Hospital and Institute
7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)
University of Missouri-Columbia
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Dana-Farber Cancer Institute
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
University of Colorado, Denver
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Tianjin First Central Hospital
Prospective Observational Study on ES-SCLC
Peking Union Medical College Hospital
SUCCEED
Addario Lung Cancer Medical Institute
A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)
Addario Lung Cancer Medical Institute
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
Indiana University
Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer
Shanghai Chest Hospital of Shanghai Jiao Tong University
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
University College, London
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
Fuzhou General Hospital
STRATUS
Oncology Center of Biochemical Education And Research
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Peking University Cancer Hospital & Institute
Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer
Hunan Cancer Hospital
CRISP
AIO-Studien-gGmbH
SCLC-OMICS
Aalborg University Hospital
A Study on the Efficacy of Atezolizumab Combined with Chemotherapy
Shanghai Pulmonary Hospital, Shanghai, China
Cognitive Screening in Lung Cancer Patients
European Institute of Oncology
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
Massachusetts General Hospital
Molecular Analysis and Treatment Options of SCLC
Shanghai Chest Hospital
CLINATEZO
Intergroupe Francophone de Cancerologie Thoracique
PET-ART
University Hospital, Essen
HYPE
University Hospital, Brest
EPITAX
University Hospital, Brest
A Multicenter Real-World Cohort Study of Adebrelimab Injection in the Treatment of Extensive-Stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer
Qingdao Central Hospital
The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer
Shandong Cancer Hospital and Institute
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Instituto Nacional de Cancerologia de Mexico
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Real-World Study on the Efficacy of IBI-322 in Combination With Lenvatinib for the Treatment of Extensive Stage Small Cell Lung Cancer
Hunan Province Tumor Hospital
ROSALIND
Cure 51
Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study
The First Hospital of Jilin University
PEER
LUNGevity Foundation
PICASSO
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
DRIVE
Hellenic Cooperative Oncology Group
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients
The Second Hospital of Shandong University
LURBICLIN
Intergroupe Francophone de Cancerologie Thoracique